Author contributions
Di Jing and Liting Shi conceived of the presented idea and supervised
the project. Kang Ren, Lin Shen, Minwu Yang, Xuan Long, Tingyin Chen,
and Hao-Yuan She prepared the sample and collected the data. Kui Sun,
Kang Ren and Di Jing defined the regions of interest and assessed
treatment response and Hematologic Toxicities. Liangfang Shen examined
treatment response. Lin Shen, Lan Deng, and Liting Shi organized the
data and calculated the radiomics features. Liting Shi and Jianfeng Qiu
designed the computational model and analyzed the data. Kang Ren, Lin
Shen, Di Jing and Liting Shi wrote the manuscript. All authors provided
critical feedback and helped shape the analysis and manuscript.
Ethics approval
Ethical
approval was granted by The ethics committee of Xiangya Hospital granted
ethical approval on November 27, 2020. The informed consent obtained
from all patients.